Production technology and chromato-mass spectroscopy of the valeriana officinalis tinctures

Authors

  • Yu. I. Korniievskyi Zaporizhzhia State Medical University, Ukraine,
  • V. M. Odyntsova Zaporizhzhia State Medical University, Ukraine,
  • V. H. Korniievska Zaporizhzhia State Medical University, Ukraine,
  • N. V. Kandybei Zaporizhzhia State Medical University, Ukraine,
  • N. Yu. Bohuslavska “Regional Perinatal Center” AOS Zaporizhzhia, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2019.2.171002

Keywords:

Valerian tinctures, chromato-mass spectroscopy, component composition, quantitative content, plant root

Abstract

 

Underground organs of Valeriana Officinalis are part of multicomponent phytocompositions, which allows them to vary the content and, thus, intensively affect various links of pathological disorders in the body. Despite this, valeriana drug remains poorly understood because of its extraordinary polymorphism.

The purpose of the work is to determine, by means of gas-liquid chromatography, the component composition of valerian tinctures produced by PrAT Pharmaceutical Factory “Viola”, made from rhizomes with valerian roots from different suppliers / manufacturers and various series.

Materials and methods. For experimental studies we took samples of tinctures of rhizomes with valerian roots produced by PRAT Pharmaceutical Factory Viola, made from medicinal plant raw materials of valerian from different suppliers / producers, namely: from firm “Herbar Sp.zoo”, Warsaw, Poland and from firm LLC “Fitosvit Ltd”, Vinnitsa region, Ukraine according to the traditional formula (Tinctura Rhizomata cum radicibus Valerianae (1: 5). Component composition of the valeriana tinctures was investigated using the gas chromatograph Agilent 7890B with a 5977B mass spectrometry detector.

Results. The component composition the of the valerian tinctures was identified by chromatography-mass spectrometry. In the analysis of the chromatogram of the four valerian tinctures series, 75 components were identified, 25 of which were present in all series of studied tinctures. It should be noted that six compounds (3, 14, 36, 40, 47, and 52) in all series are present in large quantities. Among them valerian acid (compound 47), the content of which in three series is almost at the same level of 3.1–3.72 %. The smallest amount is contained in the tincture of valerian from the raw materials of LLC "Fitosvit Ltd" 150518 series and is 1.54 %, and the biggest amount in the tincture by firm "Herbar" series 040118–3.72 %.

Conclusions. Analyzing the obtained data of the GLC it can be noted that valerian tinctures differ both on quantitative and qualitative composition. 25 compounds are present in all investigated series, 6 of which are present in large amounts. Since the tinctures were made in one technology, the content of essential oils in the medicinal plant depends by the place, time of collection, drying of raw materials, ecology, climatic latitudes. Deeper pharmacological and pharmacological research is needed on the territory of Ukraine.

References

Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv» (2016). Derzhavna farmakopeia Ukrainy [State Pharmacopoeia of Ukraine], Vol. 2. Kharkiv. [in Ukrainian].

Korniievskyi, Yu. I., Korniievska, V. H., Panchenko, S. V., & Bohuslavska, N. Yu. (2014) Valeriana likarska. [Valerian Medicines]. Zaporizhzhia : ZDMU. [in Ukrainian].

Korniievska, V. H., Sur, S. V., & Lesyk, I. P. (2000) Efirna oliia valeriany likarskoi [On stepwise control of tablet production]. Farmatsevtychnyi zhurnal, 3, 95–97. [in Ukrainian].

Korniievska, V. H., Sur, S. V., Korniievskyi, Yu. I., & Fursa, M. S. (2000) Sklad efirnoi olii – diahnostychna oznaka syrovyny valeriany [Composition of essential oil – diagnostic sign of raw materials of valerian]. Nauchnye napravleniya v sozdanii lekarstvennykh sredstv v farmacevticheskom sektore Ukrainy Abstracts of Papers of the Scientific Conference, (P. 154–156). Kharkiv. [in Ukrainian].

(2017) Tekhnolohichnyi rehlament TP 64-01973472-069-17 na vyrobnytstvo likarskoho zasobu «Valeriany nastoika, nastoika po 25 ml u flakonakh v pachtsi abo bez pachky». Zaporizhzhia: Viola. [in Ukrainian].

Kryvenko, V. I., Korniievskyi, Yu. I., Kolesnyk, M. Yu., Korniievska, V. H., & Demchenko, A. V. (2018) Fitoterapiia insomnia [Phytotherapy of insomnia]. Zaporizhzhia: ZDMU. [in Ukrainian].

(1999) American Herbal Pharmacopoeia Valerian Root.

Bos, R., Hendriks, H., Pras, N., Stojanova, A. S. & Georgiev, E. V. (2000) Essential oil composition of Valeriana officinalis ssp. collina cultivated in Bulgaria. J. Essent. Oil Res., 12(3), 313–316. doi: 10.1080/10412905.2000.9699524

(2003) ESCOP Monographs. ESCOP, Thieme, London.

(2005) European Pharmacopoeia. Vol. 2. Council of Europe, Strasbourg.

Pavlovic, M., Kovacevic, N., Tzakou, O. & Couladis, M. (2004) The essential oil of Valeriana officinalis L. s. l. growing wild in Western Serbia. J. Essent. Oil Res., 16, 397–399. https://doi.org/10.1080/10412905.2004.9698753

Raal, A., Orav, A., Arak, E., Kailas, T., & Müürisepp M. (2007) Variation in the composition of the essential oil of Valeriana officinalis L. roots from Estonia. Proc. Estonian Acad. Sci. Chem., 56(2), 67–74.

WHO (1999). WHO Monographs on Selected Medicinal Plants. (Vol. 1), (P. 267–276). Geneva.

Downloads

How to Cite

1.
Korniievskyi YI, Odyntsova VM, Korniievska VH, Kandybei NV, Bohuslavska NY. Production technology and chromato-mass spectroscopy of the valeriana officinalis tinctures. Current issues in pharmacy and medicine: science and practice [Internet]. 2019Jun.24 [cited 2024Apr.25];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/171002

Issue

No. 2 (2019)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)